BioXcel Therapeutics, Inc. - Common Stock (BTAI)

Last Price0.0739

Change-0.0436 (-37.11%)

NASDAQ· Last Trade: Sep 5th, 2:42 PM EDT

Detailed Quote

Previous Close	0.1175
Open	0.0927
Bid	0.0421
Ask	0.0422
Day's Range	0.0690 - 0.0935
52 Week Range	0.0690 - 4.290
Volume	47,480,753
Market Cap	1.48M
PE Ratio (TTM)	-0.0026
EPS (TTM)	-28.4
Dividend & Yield	N/A (N/A)
1 Month Average Volume	15,094,080

About BioXcel Therapeutics, Inc. - Common Stock (BTAI)

Bioxcel Therapeutics is a biopharmaceutical company focused on innovative drug development to address unmet medical needs in the fields of neurology and psychiatry. Utilizing its proprietary artificial intelligence platform, the company aims to identify and advance novel therapeutics that can improve patient outcomes in challenging conditions such as agitation in Alzheimer's patients and cancer-related symptoms. Bioxcel's approach integrates data-driven decision-making and clinical research to bring forth potential treatments that enhance the quality of life for patients dealing with complex health issues. Read More

BioXcel Therapeutics, Inc. - Common Stock (BTAI)

Detailed Quote

Chart

About BioXcel Therapeutics, Inc. - Common Stock (BTAI)

News & Press Releases